Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayfer Geduk

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Eurasian Journal of Medicine|January 23, 2015
Candida glabrata perinephric abscessIlker Inanc Balkan, Arif Savas, Ayfer Geduk, et al.
European Journal of Haematology|June 5, 2013
Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemiaPinar Tarkun, Ozgur Mehtap, Elif B Atesoğlu, et al.
Case Reports in Obstetrics and Gynecology|March 4, 2014
Five cases of non-hodgkin B-cell lymphoma of the ovaryTaylan Senol, Emek Doger, Ilker Kahramanoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical StudyAyfer Geduk, Elif B Atesoglu, Pinar Tarkun, et al.
Internal Medicine (Tokyo, Japan)|December 16, 2015
Late-onset Anticonvulsant Hypersensitivity Syndrome Mimicking LymphomaAyfer Geduk, Elif Birtas Atesoglu, Ozgur Mehtap, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 24, 2022
Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid LeukemiaAyfer Geduk, Elif B Atesoglu, Ozgur Mehtap, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2014
Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP ImmunopathogenesisElif Birtas Atesoglu, Pinar Tarkun, Esra Terzi Demirsoy, et al.
European Journal of Haematology|September 16, 2014
Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?Pinar Tarkun, Figen Atalay, Elif Birtas Atesoglu, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 2, 2022
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life StudyMuzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk, et al.
Leukemia Research|April 25, 2016
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter studyOzan Salim, Tayfur Toptas, Esin Avsar, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Eurasian Journal of Medicine|January 23, 2015
Candida glabrata perinephric abscessIlker Inanc Balkan, Arif Savas, Ayfer Geduk, et al.
European Journal of Haematology|June 5, 2013
Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemiaPinar Tarkun, Ozgur Mehtap, Elif B Atesoğlu, et al.
Case Reports in Obstetrics and Gynecology|March 4, 2014
Five cases of non-hodgkin B-cell lymphoma of the ovaryTaylan Senol, Emek Doger, Ilker Kahramanoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical StudyAyfer Geduk, Elif B Atesoglu, Pinar Tarkun, et al.
Internal Medicine (Tokyo, Japan)|December 16, 2015
Late-onset Anticonvulsant Hypersensitivity Syndrome Mimicking LymphomaAyfer Geduk, Elif Birtas Atesoglu, Ozgur Mehtap, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 24, 2022
Programmed Cell Death Ligand 1 Expression Level and Prognostic Significance in Acute Myeloid LeukemiaAyfer Geduk, Elif B Atesoglu, Ozgur Mehtap, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 17, 2014
Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP ImmunopathogenesisElif Birtas Atesoglu, Pinar Tarkun, Esra Terzi Demirsoy, et al.
European Journal of Haematology|September 16, 2014
Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?Pinar Tarkun, Figen Atalay, Elif Birtas Atesoglu, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 2, 2022
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life StudyMuzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk, et al.
Leukemia Research|April 25, 2016
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter studyOzan Salim, Tayfur Toptas, Esin Avsar, et al.
Pageof 2